跳至主要内容
临床试验/NCT04189016
NCT04189016Unknown不适用

Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation Via a Salt Particle Inhaler at COPD, Asthma and Healthy Individuals

Liita Care ApS2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
31
试验地点
2
主要终点
Nasal Mucociliary Clearance

研究概览

简要总结

Investigating nasal muco-ciliary clearance by scintigraphy

详细描述

The velocity and the retention of the nasal muco-ciliary clearance is going to be investigated with a salt particle inhaler and a placebo by the method nasal scintigraphy.

The hypotheses is that nasal inhalation of salt particles enhance the nasal mucociliary clearance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COPD patients (all severities in chronic, stable condition)
  • Asthma patients (in stable condition without acute asthma symptoms)
  • Healthy subjects, incl. smokers (no chronic nasal, upper or lower respiratory diseases)

排除标准

  • Age under 18 years
  • Upper respiratory tract infection / cold within the last 3 weeks and at least 3 weeks must pass from the person has become well to the examination
  • Allergic / non-allergic rhinitis (hay fever)
  • Chronic sinusitis
  • Acute respiratory tract infection in antibiotic therapy
  • Applied salt inhalation within the past month
  • Pregnant or breastfeeding women
  • Nuclear medical examination within the past month
  • Cannot taste saccharin

结局指标

主要结局

Nasal Mucociliary Clearance

时间窗: At study day 1 and 2

Change in nasal mucociliary clearance velocity (mm/min) from placebo to salt inhalation

次要结局

  • Spirometry(At the beginning and the end of study day 1 and 2)
  • Saccharin test(At study day 1 and 2)

研究者

发起方
Liita Care ApS
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Nasal Muco-ciliary Clearance Study With and Without... | 临床试验